Formula Structure (Lansoprazole Delayed Release Capsules 1)
Lansoprazole
Product Images NDC 71335-1521
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 71335-1521). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Lansoprazole Delayed Release Capsules 2)
This is a graph (Figure 1) showing the average severity of heartburn per day, represented by a scale of 0 (none) to 3 (severe) for patients in a study. The study includes patients who received either a placebo or different doses of lansoprazole (15mg or 30mg). The x-axis represents the study days, and the y-axis represents the mean severity of heartburn. There are no discernible times or dates.*
Figure 2 (Lansoprazole Delayed Release Capsules 3)
Label Image (Lbl713351521)
This appears to be a medication label for Lansoprazole DR 30mg capsules produced by Lannett Company Inc. The label contains information about the dosage, storage instructions, expiration date, and manufacturer.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
